HealdP., YanS.L., EdelsonR.. Profound deficiency in normal circulating T cells in erythrodermic cutaneous T-cell lymphoma.Arch Dermatol.1994; 130: 198–203.
5.
PosnerL.E., FossieckBEJr, EddyJ.L.. Septicemic complications of the cutaneous T-cell lymphomas.Am J Med.1981; 71: 210–216.
6.
JackowC.M., CatherJ.C., HearneV.. Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, an oligoclonal T-cell receptor V beta gene expansion.Blood.1997; 89: 32–40.
7.
PinkasH.. Mycosis fungoides and histoplasmosis.Arch Dermatol.1968; 98: 323–325.
8.
OlsenE.A., DelzellE., JegasothyB.V.. Second malignancies in cutaneous T cell lymphoma.J Am Acad Dermatol.1984; 10: 197–204.
9.
KantorA.F., CurtisR.E., VonderheidE.C.. Risk of second malignancy after cutaneous T-cell lymphoma.Cancer.1989; 63: 1612–1615.
FriedenT.R., BiaF.J., HealdP.W.. Cutaneous cryptococcosis in a patient with cutaneous T cell lymphoma receiving therapy with photopheresis and methotrexate.Clin Infect Dis.1993; 17: 776–778.
14.
EpsteinEHJr, LevinD.L., CroftJDJr. Mycosis fungoides: survival, prognostic features, response to therapy, and autopsy findings.Medicine.1972; 51: 61–72.
15.
GrossmanD., RapiniR.P., OsborneB.. Emergence of leprosy in a patient with mycosis fungoides.J Am Acad Dermatol.1994; 30: 313–315.